I-Corps alum Assurtek Surgical is commercializing the world’s first AI-powered dental drill technology.
read more
Nanopath is developing molecular diagnostic platforms to detect viral, bacterial, and fungal pathogens using a single patient sample.
read more
Angelo Niforatos, a recent Syracuse University graduate with master’s degrees in engineering and business, used his NSF I-Corps experience to accelerate his startup, Niffy Drone Solutions.
read more
I-Corps alum Burlington Bio, a biotech startup spun out of the University of Vermont, was recently awarded a $305,000 Phase I SBIR grant from the NSF.
read more
I-Corps alum Biobe, a startup founded at the University of Vermont, is leading the conversation around emotional wellness for children and families.
read more
Dr. Yuguang Chris Li, Assistant Professor of Chemistry at University at Buffalo, founded PlasmaChem Solutions to commercialize a novel plasma-based method to more efficiently convert atmospheric nitrogen and water into ammonia.
read more
Dr. Andrew Talal, a University at Buffalo Professor of Medicine and leading liver disease expert, first participated in I-Corps in 2020 to evaluate the market fit of a facilitated telemedicine approach for hepatitis C (HCV) treatment in opioid treatment programs.
read more
Bluminate (formerly VAPGuard) is transforming infection prevention in critical care with a novel, patent-pending medical device that reduces the risk of the most costly and deadly hospital-acquired infections, such as ventilator-associated pneumonia and catheter-associated urinary tract infections.
read more
Cellec Technologies incorporated in 2016 after completing the NSF I-Corps national program and successfully identifying a product-market fit through customer discovery.
read more
Pittsburgh-based Surface Design Solutions has raised $925,000 and hired four employees to help manufacturers achieve dramatic cost reductions by optimizing surfaces.
read more